Full Product Name
GFM1 siRNA (Mouse)
Product Synonym Names
EFG; EFG1; GFM; Elongation factor G mitochondrial; EF-Gmt; Elongation factor G 1 mitochondrial; mEF-G 1; Elongation factor G1
Product Gene Name
GFM1 sirna
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q8K0D5
Specificity
GFM1 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Purity/Purification
> 97%
Form/Format
Lyophilized powder
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of mouse GFM1 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Negative Control
siRNA Negative Control (Catalog# MBS8241404) is a non-targeting 21 nt siRNA recommended as a negative control for experiments using targeted siRNA transfection.
Other Notes
Small volumes of GFM1 sirna vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
GFM1 sirna
siRNA to inhibit GFM1 expression using RNA interference
Applications Tested/Suitable for GFM1 sirna
RNA Interference (RNAi)
NCBI/Uniprot data below describe general gene information for GFM1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_613057.2
[Other Products]
NCBI GenBank Nucleotide #
NM_138591.2
[Other Products]
UniProt Primary Accession #
Q8K0D5
[Other Products]
UniProt Secondary Accession #
Q921D6; Q924I0[Other Products]
UniProt Related Accession #
Q8K0D5[Other Products]
Molecular Weight
83,550 Da
NCBI Official Full Name
elongation factor G, mitochondrial
NCBI Official Synonym Full Names
G elongation factor, mitochondrial 1
NCBI Official Symbol
Gfm1 [Similar Products]
NCBI Official Synonym Symbols
Gfm; AW545374; D3Wsu133e
[Similar Products]
NCBI Protein Information
elongation factor G, mitochondrial
UniProt Protein Name
Elongation factor G, mitochondrial
UniProt Synonym Protein Names
Elongation factor G 1, mitochondrial
UniProt Gene Name
Gfm1 [Similar Products]
UniProt Synonym Gene Names
Efg; Efg1; Gfm; EF-Gmt; mEF-G 1 [Similar Products]
UniProt Entry Name
EFGM_MOUSE
UniProt Comments for GFM1
EFG1: Mitochondrial GTPase that catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A- site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome. Does not mediate the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. Defects in GFM1 are the cause of combined oxidative phosphorylation deficiency type 1 (COXPD1). It leads to early fatal progressive hepatoencephalopathy. Belongs to the GTP-binding elongation factor family. EF-G/EF-2 subfamily. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Mitochondrial; RNA-binding; Translation elongation
Cellular Component: mitochondrion; intracellular
Molecular Function: GTPase activity; GTP binding; nucleotide binding; translation elongation factor activity
Biological Process: translational elongation; translation
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
